Keybanc Initiates Coverage of IDEXX Laboratories at Sector Weight
Fintel reports that on October 12, 2026, Keybanc initiated coverage of IDEXX Laboratories (NASDAQGS:IDXX) (XTRA:IX1) with a Sector Weight recommendation.
IDEXX Laboratories, Inc., based in the United States, operates primarily within the veterinary diagnostics sector, along with providing associated veterinary software and services. The company's portfolio includes diagnostic technologies such as the Catalyst Dx chemistry analyzer and the SediVue Dx Urine Sediment Analyzer, and its Water division contributes globally to water quality testing. Prior to the rating action, the stock closed at $518.00 on October 9, 2026. This latest close of $518.00 represents a price change of -0.08% over one week, compared to a baseline close of $518.39 on October 2, 2026. Over a one-month period, the stock experienced a price change of +0.55% from a baseline close of $515.15 on September 9, 2026.
In its latest earnings report on August 4, 2026, IDEXX Laboratories reported an actual EPS of 4.27, which was above the estimated EPS of 4.0205, representing an EPS surprise of +6.21%. The company's actual revenue for the quarter was $1,216,585,000.00, compared to an estimated revenue of $1,224,623,934.00. The upcoming earnings date is scheduled for November 2, 2026, during the before market open session.
Separately from Keybanc's individual rating, the current consensus target for IDEXX Laboratories as of October 2, 2026, includes a mean target of $723.29 and a median target of $724.20. This mean target represents an implied change of +39.63% from previous levels. The prior consensus target mean was $720.44 as of September 15, 2026, reflecting a consensus target revision of +0.40%. As of the current recommendation period starting September 1, 2026, the aggregate analyst recommendation distribution consists of 7 strong buy, 7 buy, 8 hold, 0 sell, and 0 strong sell recommendations, totaling 22 recommendations. This distribution shows 63.6% positive, 36.4% hold, and 0.0% negative recommendations, which remains unchanged from the prior recommendation period starting August 1, 2026, which also had 22 total recommendations with the same percentages.
Recent analyst actions
| Date | Analyst | Prior | Latest recommendation | Action |
|---|---|---|---|---|
| October 12, 2026 | Keybanc | Sector Weight | initiated coverage |
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.